Skip to main content
Fig. 1 | AIDS Research and Therapy

Fig. 1

From: Early ART-initiation and longer ART duration reduces HIV-1 proviral DNA levels in children from the CHER trial

Fig. 1

Overview of the CHER trial treatment strategies and median duration on ART within arms from participants analysed for HIV proviral DNA. Median time to ART initiation in the deferred arm, ART-Def, was 26.1 weeks (IQR 20–42.9, n  =  79). Median duration of ART-interruption for ART-40 W was 31.3 (12.5–54.3, n  =  56) and 52.3 (11.4–152, n  =  94) weeks in ART-96 W

Back to article page

AIDS Research and Therapy

ISSN: 1742-6405

Contact us